These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 25427164)

  • 1. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.
    Iguchi T; Shirabe K; Aishima S; Wang H; Fujita N; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Oda Y; Maehara Y
    Transplantation; 2015 Jun; 99(6):1236-42. PubMed ID: 25427164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
    Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
    Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin.
    Shirabe K; Itoh S; Yoshizumi T; Soejima Y; Taketomi A; Aishima S; Maehara Y
    J Surg Oncol; 2007 Mar; 95(3):235-40. PubMed ID: 17323337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
    Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
    Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
    Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
    Shimada M; Yonemura Y; Ijichi H; Harada N; Shiotani S; Ninomiya M; Terashi T; Yoshizumi T; Soejima Y; Maehara Y
    Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
    Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
    Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.
    Sumie S; Nakashima O; Okuda K; Kuromatsu R; Kawaguchi A; Nakano M; Satani M; Yamada S; Okamura S; Hori M; Kakuma T; Torimura T; Sata M
    Ann Surg Oncol; 2014 Mar; 21(3):1002-9. PubMed ID: 24254204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
    Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
    Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation for hepatocellular carcinoma.
    Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
    Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.
    Cucchetti A; Piscaglia F; Grigioni AD; Ravaioli M; Cescon M; Zanello M; Grazi GL; Golfieri R; Grigioni WF; Pinna AD
    J Hepatol; 2010 Jun; 52(6):880-8. PubMed ID: 20409605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
    Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
    BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
    Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
    Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
    Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
    Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma.
    Nitta H; Allard MA; Sebagh M; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Lewin M; Samuel D; Baba H; Adam R
    Ann Surg Oncol; 2019 Aug; 26(8):2568-2576. PubMed ID: 31054040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.